| Jun 12 |
Affimed says 86% of patients responded to lymphoma therapy in mid-stage trial
|
| Jun 12 |
Affimed N.V. 2024 Q1 - Results - Earnings Call Presentation
|
| Jun 12 |
Affimed reports Q1 results
|
| Jun 12 |
Affimed Reports First Quarter 2024 Financial Results & Business Update
|
| Jun 11 |
Affimed: AFM24's Update Was Good, Acimtamig's Should Be Better
|
| Jun 7 |
Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?
|
| Jun 5 |
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024
|
| Jun 4 |
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study
|
| Jun 4 |
Is Affimed (AFMD) Outperforming Other Medical Stocks This Year?
|
| Jun 3 |
Why Is German Biotech Affimed Stock Soaring On Monday?
|
